Foscarnet administered by portable infusion device in AIDS patients with CMV infection

AIDS Patient Care STDS. 1997 Apr;11(2):76-8. doi: 10.1089/apc.1997.11.76.

Authors

A Bicart-Sée¹, M Obadia, C Gonzalez, S Averous, M Maurette, J C Auvergnat

Affiliation

¹ Department of Infectious Diseases, Hôpitaux de Toulouse, France.

PMID: 11361767
DOI: 10.1089/apc.1997.11.76

No abstract available

Publication types

Clinical Trial

MeSH terms

AIDS-Related Opportunistic Infections / diagnosis
AIDS-Related Opportunistic Infections / drug therapy*
AIDS-Related Opportunistic Infections / mortality
Adult
Antiviral Agents / administration & dosage*
Cytomegalovirus Infections / diagnosis
Cytomegalovirus Infections / drug therapy*
Cytomegalovirus Infections / mortality
Dose-Response Relationship, Drug
Equipment Design
Female
Follow-Up Studies
Foscarnet / administration & dosage*
Humans
Infusion Pumps, Implantable*
Infusions, Intravenous
Male
Middle Aged
Quality of Life
Survival Rate
Treatment Outcome

Substances

Antiviral Agents
Foscarnet